China State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Developmental Biology and Molecular Medicine, Institute of Metabolism and Integrative Biology, Human Phenome Institute, Children's Hospital, Department of Liver Surgery and Transplantation of Liver Cancer Institute at Zhongshan Hospital, Fudan University, Shanghai 200438, China.
China State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.
Life Sci. 2023 Sep 1;328:121902. doi: 10.1016/j.lfs.2023.121902. Epub 2023 Jun 29.
The small GTPase protein ARF1 has been shown to be involved in the lipolysis pathway and to selectively kill stem cells in Drosophila melanogaster. However, the role of ARF1 in mammalian intestinal homeostasis remains elusive. This study aimed to explore the role of ARF1 in intestinal epithelial cells (IECs) and reveal the possible mechanism.
IEC-specific ARF1 deletion mouse model was used to evaluate the role of ARF1 in intestine. Immunohistochemistry and immunofluorescence analyses were performed to detect specific cell type markers, and intestinal organoids were cultured to assess intestinal stem cell (ISC) proliferation and differentiation. Fluorescence in situ hybridization, 16S rRNA-seq analysis, and antibiotic treatments were conducted to elucidate the role of gut microbes in ARF1-mediated intestinal function and the underlying mechanism. Colitis was induced in control and ARF1-deficient mice by dextran sulfate sodium (DSS). RNA-seq was performed to elucidate the transcriptomic changes after ARF1 deletion.
ARF1 was essential for ISC proliferation and differentiation. Loss of ARF1 increased susceptibility to DSS-induced colitis and gut microbial dysbiosis. Gut microbiota depletion by antibiotics could rescue the intestinal abnormalities to a certain extent. Furthermore, RNA-seq analysis revealed alterations in multiple metabolic pathways.
This work is the first to elucidate the essential role of ARF1 in regulating gut homeostasis, and provides novel insights into the pathogenesis of intestinal diseases and potential therapeutic targets.
小分子 GTP 酶蛋白 ARF1 已被证明参与脂肪分解途径,并能在黑腹果蝇中选择性杀死干细胞。然而,ARF1 在哺乳动物肠道稳态中的作用仍不清楚。本研究旨在探索 ARF1 在肠上皮细胞(IEC)中的作用,并揭示可能的机制。
使用 IEC 特异性 ARF1 缺失小鼠模型来评估 ARF1 在肠道中的作用。进行免疫组织化学和免疫荧光分析以检测特定细胞类型标志物,并培养肠类器官以评估肠干细胞(ISC)的增殖和分化。进行荧光原位杂交、16S rRNA-seq 分析和抗生素处理,以阐明肠道微生物在 ARF1 介导的肠道功能中的作用及其潜在机制。用葡聚糖硫酸钠(DSS)诱导对照和 ARF1 缺失小鼠发生结肠炎。进行 RNA-seq 以阐明 ARF1 缺失后的转录组变化。
ARF1 对 ISC 的增殖和分化至关重要。ARF1 的缺失增加了对 DSS 诱导的结肠炎和肠道微生物失调的易感性。抗生素耗尽肠道微生物在一定程度上可以挽救肠道异常。此外,RNA-seq 分析显示多个代谢途径发生改变。
这项工作首次阐明了 ARF1 在调节肠道稳态中的重要作用,为肠道疾病的发病机制和潜在治疗靶点提供了新的见解。